Literature DB >> 26005698

The pERK of being a target: Kinase regulation of the orphan nuclear receptor ERRγ.

Rebecca B Riggins1.   

Abstract

Estrogen-related receptors (ERRs) are orphan members of the nuclear receptor superfamily that are important regulators of mitochondrial metabolism with emerging roles in cancer. In the absence of an endogenous ligand, ERRs are reliant upon other regulatory mechanisms that include protein/protein interactions and post-translational modification, though the cellular and clinical significance of this latter mechanism is unclear. We recently published a study in which we establish estrogen-related receptor gamma (ERRγ) as a target for extracellular signal-regulated kinase (ERK), and show that regulation of ERRγ by ERK has important consequences for the function of this receptor in cellular models of estrogen receptor-positive (ER+) breast cancer. In this Research Highlight, we discuss the implications of these findings from a molecular and clinical perspective.

Entities:  

Keywords:  ERK/MAPK; ERRgamma; ESRRG; orphan nuclear receptor; tamoxifen; transcription

Year:  2014        PMID: 26005698      PMCID: PMC4440692     

Source DB:  PubMed          Journal:  Receptors Clin Investig


  38 in total

1.  ERK/MAPK regulates ERRγ expression, transcriptional activity and receptor-mediated tamoxifen resistance in ER+ breast cancer.

Authors:  Mary M Heckler; Hemang Thakor; Cara C Schafer; Rebecca B Riggins
Journal:  FEBS J       Date:  2014-04-28       Impact factor: 5.542

Review 2.  The orphan nuclear receptors at their 25-year reunion.

Authors:  Shannon E Mullican; Joanna R Dispirito; Mitchell A Lazar
Journal:  J Mol Endocrinol       Date:  2013-11-26       Impact factor: 5.098

Review 3.  Oestrogen-related receptors in breast cancer: control of cellular metabolism and beyond.

Authors:  Geneviève Deblois; Vincent Giguère
Journal:  Nat Rev Cancer       Date:  2012-11-29       Impact factor: 60.716

4.  Translational analysis of mouse and human placental protein and mRNA reveals distinct molecular pathologies in human preeclampsia.

Authors:  Brian Cox; Parveen Sharma; Andreas I Evangelou; Kathie Whiteley; Vladimir Ignatchenko; Alex Ignatchenko; Dora Baczyk; Marie Czikk; John Kingdom; Janet Rossant; Anthony O Gramolini; S Lee Adamson; Thomas Kislinger
Journal:  Mol Cell Proteomics       Date:  2011-10-10       Impact factor: 5.911

Review 5.  Variable steroid receptor responses: Intrinsically disordered AF1 is the key.

Authors:  S Stoney Simons; Raj Kumar
Journal:  Mol Cell Endocrinol       Date:  2013-06-17       Impact factor: 4.102

6.  Phosphorylation and intramolecular stabilization of the ligand binding domain in the nuclear receptor steroidogenic factor 1.

Authors:  Marion Desclozeaux; Irina N Krylova; Florence Horn; Robert J Fletterick; Holly A Ingraham
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

7.  Regulation of estrogen receptor nuclear export by ligand-induced and p38-mediated receptor phosphorylation.

Authors:  Heehyoung Lee; Wenlong Bai
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

8.  Phosphorylation-dependent sumoylation regulates estrogen-related receptor-alpha and -gamma transcriptional activity through a synergy control motif.

Authors:  Annie M Tremblay; Brian J Wilson; Xiang-Jiao Yang; Vincent Giguère
Journal:  Mol Endocrinol       Date:  2007-12-06

9.  Deoxyribonucleic acid response element-dependent regulation of transcription by orphan nuclear receptor estrogen receptor-related receptor gamma.

Authors:  Sabyasachi Sanyal; Jason Matthews; Didier Bouton; Han-Jong Kim; Hueng-Sik Choi; Eckardt Treuter; Jan-Ake Gustafsson
Journal:  Mol Endocrinol       Date:  2003-11-26

10.  Effect of aromatase inhibition on functional gene modules in estrogen receptor-positive breast cancer and their relationship with antiproliferative response.

Authors:  Qiong Gao; Neill Patani; Anita K Dunbier; Zara Ghazoui; Marketa Zvelebil; Lesley-Ann Martin; Mitch Dowsett
Journal:  Clin Cancer Res       Date:  2014-03-14       Impact factor: 12.531

View more
  2 in total

1.  Insights into the activation mechanism of human estrogen-related receptor γ by environmental endocrine disruptors.

Authors:  Erwan Thouennon; Vanessa Delfosse; Rémy Bailly; Pauline Blanc; Abdelhay Boulahtouf; Marina Grimaldi; Alessandro Barducci; William Bourguet; Patrick Balaguer
Journal:  Cell Mol Life Sci       Date:  2019-05-24       Impact factor: 9.261

2.  ERRγ target genes are poor prognostic factors in Tamoxifen-treated breast cancer.

Authors:  Subha Madhavan; Yuriy Gusev; Salendra Singh; Rebecca B Riggins
Journal:  J Exp Clin Cancer Res       Date:  2015-05-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.